Monocytes and Macrophages in Alpha-I Antitrypsin Deficiency
Open Access
- 1 January 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. 15, 3183-3192
- https://doi.org/10.2147/COPD.S276792
Abstract
Alpha-1 antitrypsin deficiency (AATD) is a genetic condition characterised by low circulating levels of alpha-1 antitrypsin (AAT), a serine proteinase inhibitor. The most common deficiency variants are the S and Z mutations, which cause the accumulation of misfolded AAT in hepatocytes resulting in endoplasmic reticular stress and insufficient release of AAT into the circulation (<11 mu mol/L). This leads to liver disease, as well as an increased risk of emphysema due to unopposed proteolytic activity of neutrophil-derived serine proteinases in the lungs. AATD has been traditionally viewed as an inflammatory disorder caused directly by a proteinase-antiproteinase imbalance in the lung, but increasing evidence suggests that low AAT levels may affect other cellular functions. Recently, AAT polymers have been identified in both monocytes and macrophages from AATD patients and evidence is building that these cells may also play a role in the development of AATD lung disease. Alveolar macrophages are phagocytic cells that are important in the lung immune response but are also implicated in driving inflammation. This review explores the potential implications of monocyte and macrophage involvement in non-liver AAT synthesis and the pathophysiology of AATD lung disease.This publication has 74 references indexed in Scilit:
- Monocytes in health and disease — MinireviewEuropean Journal of Microbiology and Immunology, 2012
- Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisDrug Design, Development and Therapy, 2011
- α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8JCI Insight, 2010
- Defective macrophage phagocytosis of bacteria in COPDEuropean Respiratory Journal, 2009
- TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic CellsImmunity, 2007
- Impaired Phagocytosis of NontypeableHaemophilus influenzaeby Human Alveolar Macrophages in Chronic Obstructive Pulmonary DiseaseThe Journal of Infectious Diseases, 2006
- Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsinBiochemical and Biophysical Research Communications, 2004
- Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cellsImmunology & Cell Biology, 2003
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.JCI Insight, 1998
- The isolation of a clone for human α 1-antitrypsin and the detection of α 1-antitrypsin in mRNA from liver and leukocytesBiochemical and Biophysical Research Communications, 1983